GGrantIndex
Sort

3,198 grants matching mrna vaccine

Effect Ultraviolet Radiation on Latent M. tuberculosis Infection in Guinea Pigs

$219,750
Amminikutty Jeevan · Texas A&M University Health Science Ctr · R21 · FY2009 · AI

Oral Delivery of RNA Encoded Antigen

$219,713
Drew Weissman · University Of Pennsylvania · R21 · FY2008 · DE

Targeting Conserved Molecular and Structural Features of Apicomplexans Towards a Rational Vaccine Design

$219,554
Kirk David Christian Jensen · University Of California, Merced · R21 · FY2024 · AI

HIV eradication by ADCC-activated NK cell killing

$217,938
Jonathan Karn · Case Western Reserve University · R21 · FY2014 · AI

HIV eradication by ADCC-activated NK cell killing

$217,938
Jonathan Karn · Case Western Reserve University · R21 · FY2015 · AI

Host defense against influenza virus in the lungs of neonatal mice

$217,900
Beth A Garvy · University Of Kentucky · R21 · FY2009 · AI

Purification of Circular RNA by Ultrafiltration

$217,771
Scott M Husson · Clemson University · R21 · FY2022 · GM

Recombinant archaeal organelles of SIV and HIV antigens

$217,708
University Of Massachusetts Amherst · R21 · FY2001 · AI

Develop and Assess mRNA Lipid Nanoparticle Vaccines Against Cryptococcosis

$217,673
Xiaorong Lin · University Of Georgia · R21 · FY2024 · AI

Measuring High Affinity Mucosal Antibody Responses

$217,669
Maria Virginia Pascual · Baylor Research Institute · U19 · FY2009 · AI

Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques

$217,604
Koen K Van Rompay · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI

Chromatin changes in the thymus epithelium during aging

$217,429
Julien Sage · Stanford University · R21 · FY2016 · AG

Global effects of flavivirus sfRNA on translation determined by ribosome profiling

$216,354
Wyatt Allen Miller · Iowa State University · R21 · FY2022 · AI

Liposome-based mRNA cancer immunotherapy targeting ion channels

$215,846
Laura Conforti · University Of Cincinnati · R21 · FY2024 · CA

Development of vaccines targeting a tick-borne phlebovirus

$215,821
Paul F Bates · University Of Pennsylvania · R01 · FY2022 · AI

Mechanism of Translation Elongation Factor 2 Inhibition by Bacterial Toxins

$215,503
Terri Goss Kinzy · Univ Of Med/Dent Nj-R W Johnson Med Sch · R21 · FY2010 · AI

Analysis of the Coxiella burnetii Type IV Secretion System During Infection

$215,424
Edward I. Shaw · Oklahoma State University Stillwater · R15 · FY2007 · AI

Disruption of Conserved RNA Stem-Loops in Filovirus RNA

$215,250
University Of Alabama At Birmingham · R21 · FY2002 · AI

Disruption of Conserved RNA Stem-Loops in Filovirus RNA

$215,250
University Of Alabama At Birmingham · R21 · FY2003 · AI

Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses

$215,100
Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Core C. Clinical Core/Human subjects

$215,035
Brendan Joseph Kelly · University Of Pennsylvania · U19 · FY2024 · AI

The role of PD-1 and SOCS-1 in HCV core/gC1qR-mediated IL-12 suppression

$214,500
Zhi Q. Yao · East Tennessee State University · R15 · FY2009 · AI

Admin Core

$214,021
Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2021 · AI

Admin Core

$214,021
Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2022 · AI

Pioneering Precision Medicine Approaches for Immune Control of Pediatric HIV-1 Infection

$213,939
Mathias Lichterfeld · Harvard University D/B/A Harvard School Of Public Health · P01 · FY2025 · HD